MENU

NERV Minerva Neurosciences Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company

Industry Biotechnology
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NERV is expected to report earnings to fall 33.03% to -73 cents per share on November 04

Minerva Neurosciences NERV Stock Earnings Reports
Q3'24
Est.
$-0.73
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.12
Q4'23
Missed
by $0.31
Q3'23
Missed
by $0.26
The last earnings report on August 06 showed earnings per share of -109 cents, missing the estimate of -97 cents. With 3.56K shares outstanding, the current market capitalization sits at 19.70M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
9
Web
https://www.minervaneurosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TW118.820.30
+0.25%
Tradeweb Markets
OCFC18.13-0.01
-0.06%
OceanFirst Financial Corp
SLAB110.79-0.89
-0.80%
Silicon Laboratories
MBOT0.93-0.01
-1.25%
Microbot Medical
OOMA11.08-0.21
-1.86%
Ooma

NERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with SYRE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-2.06%
SYRE - NERV
35%
Loosely correlated
+1.58%
MIST - NERV
27%
Poorly correlated
+1.31%
OCUP - NERV
27%
Poorly correlated
+1.53%
SWTX - NERV
26%
Poorly correlated
+0.45%
ATOS - NERV
24%
Poorly correlated
-2.07%
More